ロード中...
Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV)
Chemotherapy-induced nausea and vomiting (CINV) is associated with a significant deterioration in quality of life. The emetogenicity of the chemotherapeutic agents, repeated chemotherapy cycles, and patient risk factors significantly influence CINV. The use of a combination of a 5-hydroxytryptamine-...
保存先:
| 出版年: | Drug Des Devel Ther |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4277122/ https://ncbi.nlm.nih.gov/pubmed/25552904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S76158 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|